健超 马

Mr. 健超 马


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BLBin Liang
Bin Liang
XQXue Qiu
Xue Qiu
JHJiansheng Huang
Jiansheng Huang
YLYequan Lu
Yequan Lu
HSHairong Shen
Hairong Shen
YCYongyu Chen
Yongyu Chen
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a globally widespread chronic liver condition that may progress to severe liver diseases, including advanced liver fibrosis. The high-sensitivity C-reactive protein-to-high-density lipoprotein cholesterol (hs-CRP/HDL-C) index may be a potential indicator for MASLD and advanced liver fibrosis, given its relevance to inflammation and plasma lipids. In this study, the hs-CRP/HDL-C index was investigated in relation to prevalent MASLD and advanced liver fibrosis. The study analyzed secondary data from the National Health and Nutrition Examination Survey (NHANES) 2017–2018 database. The hs-CRP/HDL-C index was calculated by the quotient of hs-CRP and HDL-C. Multiple logistic regression models, Cochran-Armitage trend tests, smooth curve fitting, threshold effect analyses, and stratified analyses were used to evaluate whether the hs-CRP/HDL-C index associated with MASLD and advanced liver fibrosis. The study cohort comprised 3684 participants, of whom 1268 (34.42%) were diagnosed with MASLD and 156 (12.28%) with advanced liver fibrosis. Logistic analyses adjusted for covariates revealed positive associations of the hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, consistent across all subgroups. Smooth curve fitting and threshold effect analyses revealed nonlinear relationships of hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, with inflection points at 0.8 for MASLD and 1.2 for advanced liver fibrosis. Additionally, significant interactions were observed between MASLD and covariates such as gender, smoking status, chronic kidney disease (CKD), and cancer. Similarly, the hs-CRP/HDL-C index exhibited positive correlations with advanced liver fibrosis across diverse subgroups, with notable interactions related to cancer. MASLD and advanced liver fibrosis were associated with hs-CRP/HDL-C index, indicating its potential utility as a clinical marker for these conditions.

16 June 2025 in Mammalian Genome
Verified
Journal Article
Closed access
PDF file
XQXue Qiu
Xue Qiu
王王王强 强 王
王强 强 王
YCYongyu Chen
Yongyu Chen
BLBin Liang
Bin Liang
JHJiansheng Huang
Jiansheng Huang
LLLang Li
Lang Li

13 February 2026 in Medicine
Verified
Journal Article
Open access
YLYouqi Lu
Youqi Lu
YCYang Cai
Yang Cai
YZYuling Zhi
Yuling Zhi
健马健超 马
健超 马
XFXu Fang
Xu Fang
GWGaomeng Wei
Gaomeng Wei
An essential instrument for evaluating older adults’ nutritional status is the geriatric nutritional risk index (GNRI). This investigation aimed to examine the connection between the GNRI and erectile dysfunction (ED) risk. Three models were created, and the connection between GNRI and ED was investigated through multiple linear and logistic regressions. The nonlinear relationship between GNRI and ED was evaluated using smooth curve fitting. To further confirm the consistency of GNRI and ED relationships across various populations, subgroup analysis, interaction tests, and sensitivity analyses were employed. The receiver operating characteristic curve was applied to evaluate how well GNRI could forecast the occurrence of ED. Among 1898 participants, GNRI was negatively associated with the risk of ED occurrence. In the fully adjusted model, the risk of ED decreases by 4% (OR = 0.96, 95% CI 0.94–0.99, P = .0032) for every 1-unit rise in GNRI. Compared with the low GNRI group ( .05). The sensitivity analysis and the receiver operating characteristic curve (with an area under curve of 0.651) demonstrate GNRI’s good predictive ability. A higher GNRI was significantly associated with a lower risk of ED occurrence. The GNRI is a reliable, independent predictor of ED occurrence in older adults.